A Phase Iiib, Randomized, Multicenter, Parallel-Group, Non-Inferiority
Research payments
$11,038,148
Through program year 2025, $11,038,148 in research payments was reported against A Phase Iiib, Randomized, Multicenter, Parallel-Group, Non-Inferiority, across 1,511 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $582,287 | 34 |
| 2024 | Research | $443,170 | 80 |
| 2023 | Research | $524,214 | 177 |
| 2022 | Research | $1,504,594 | 238 |
| 2021 | Research | $2,369,327 | 334 |
| 2020 | Research | $2,386,126 | 324 |
| 2019 | Research | $3,228,431 | 324 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Chiu Bin Hsiao Pittsburgh, PA Named on 66 payments
- Anthony Scarsella Beverly Hills, CA Named on 39 payments
- Princy Kumar Washington, DC Named on 35 payments
- Anthony Mills Los Angeles, CA Named on 32 payments
- Gary Richmond Fort Lauderdale, FL Named on 32 payments
- Cheryl Newman Augusta, GA Named on 31 payments
- David Wohl Chapel Hill, NC Named on 29 payments
- Christopher Polk Charlotte, NC Named on 24 payments
- Susan Swindells Omaha, NE Named on 24 payments
- David Wheeler Annandale, VA Named on 24 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.